{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidgnszrmimmu2agko7eaqsjzcinn7khkcvcgcfctfhmoeqj7ykrwq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mghd6tj4pc22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic6aqofi4n67gpjjlg7ouxobksvkjbmrfld2peiopxnbpvnstk6li"
    },
    "mimeType": "image/jpeg",
    "size": 58441
  },
  "path": "/2026/03/06/fda-vinay-prasad-controversial-cber-director-leaving/?utm_campaign=rss",
  "publishedAt": "2026-03-06T22:11:49.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Breaking News",
    "Politics",
    "drug development",
    "FDA",
    "HHS",
    "Policy",
    "White House"
  ],
  "textContent": "Prasad has been involved in several controversial decisions related to rare disease treatments.",
  "title": "Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency",
  "updatedAt": "2026-03-07T00:31:18.000Z"
}